manufacturer of biologics

Samsung Biologics is a world-leading contract development and manufacturing organization (CDMO) based in South Korea, specializing in the large-scale production of biologic medicines. Founded in 2011 as a joint venture between Samsung and Quintiles, the company has rapidly expanded to become the world's largest biologics manufacturer by production capacity. It provides a comprehensive range of services including cell line development, process development, and cGMP manufacturing for drug substances and drug products. Samsung Biologics operates multiple state-of-the-art facilities in Songdo, including its massive Plant 4, and is currently constructing Plant 5 to further cement its market dominance. The company serves major global pharmaceutical partners such as Bristol Myers Squibb, Roche, and AstraZeneca, delivering high-quality monoclonal antibodies and next-generation modalities like ADCs and mRNA.